Affiliation:
1. Gamaleya Research Institute, Moscow 123098, Russia
2. Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, D-79104 Freiburg, Germany
Abstract
ABSTRACT
Legionella pneumophila
is a facultative intracellular pathogen responsible for severe lung disease in humans, known as legionellosis or Legionnaires' disease. Previously, we reported on the ∼60-kDa glucosyltransferase (Lgt1) from
Legionella pneumophila
, which modified eukaryotic elongation factor 1A. In the present study, using
L. pneumophila
Philadelphia-1, Lens, Paris, and Corby genome databases, we identified several genes coding for proteins with considerable sequence homology to Lgt1. These new enzymes form three subfamilies, termed Lgt1 to -3, glucosylate mammalian elongation factor eEF1A at serine-53, inhibit its activity, and subsequently kill target eukaryotic cells. Expression studies on
L. pneumophila
grown in broth medium or in
Acanthamoeba castellanii
revealed that production of Lgt1 was maximal at stationary phase of broth culture or during the late phase of
Legionella
-host cell interaction, respectively. In contrast, synthesis of Lgt3 peaked during the lag phase of liquid culture and at early steps of bacterium-amoeba interaction. Thus, the data indicate that members of the
L. pneumophila
glucosyltransferase family are differentially regulated, affect protein synthesis of host cells, and represent potential virulence factors of
Legionella
.
Publisher
American Society for Microbiology
Subject
Molecular Biology,Microbiology